Label-free quantitative proteomic analysis reveals potential biomarkers for early healing in cutaneous leishmaniasis.

We identified changes in the profiles of proteins that had a positive therapeutic response to the treatment. The proteins identified with differential expression are related to the reduction of inflammation and increased tissue repair. These proteins can be useful as biomarkers for early monitoring of therapeutic response in CL.